Mitochondrial fusion and its role in insulin release
Control of insulin secretion by mitochondrial fusion
This research looks at whether proteins that help mitochondria merge (Mfn1 and Mfn2) change how insulin is released from pancreatic beta cells in people with adult-onset (type 2) diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11397275 on NIH RePORTER |
What this research studies
This project focuses on proteins called mitofusins (Mfn1 and Mfn2) that help mitochondria fuse inside pancreatic beta cells. Researchers will alter these proteins in lab and animal models and examine human islets and other samples to see how mitochondrial DNA and network stability are affected. They will measure how these mitochondrial changes influence insulin production, processing, and the coordinated activity of beta cells. The goal is to understand how problems with mitochondrial fusion can lead to beta-cell failure in type 2 diabetes.
Who could benefit from this research
Good fit: Ideal participants would be adults with type 2 diabetes or donors willing to provide pancreatic tissue or other biospecimens for research.
Not a fit: People with type 1 diabetes or conditions unrelated to beta-cell mitochondrial function are unlikely to receive direct benefit from this research.
Why it matters
Potential benefit: If successful, the work could point to new ways to protect or restore beta-cell function and improve insulin release for people with type 2 diabetes.
How similar studies have performed: Prior lab and animal research has linked mitochondrial defects and lower mitofusin levels to beta-cell problems in type 2 diabetes, but translating these findings into therapies is still largely untested.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Soleimanpour, Scott — University of Michigan at Ann Arbor
- Study coordinator: Soleimanpour, Scott
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.